Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02567500
Other study ID # 14-HPNCL-02
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 7, 2015
Est. completion date July 7, 2017

Study information

Verified date July 2018
Source Fondation Lenval
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to show presence of cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. Investigators will describe a significant link between this factors and hallucinations in a sample of non-psychotic children. The results of this sample will be comparing to another group of children of the same age, sex and diagnosis, but without hallucination. Finally, investigators will control the persistence of hallucination on the first group after a six month period.


Description:

Background: Hallucinations are a common symptom in pediatric population without psychotic syndrome. Vulnerability, co morbidity and risk factor are already been described. Investigators will study the cognitive and emotional factors on the beginning and persistence of auditory hallucinations in non-psychotic children. The goal of the study is to find a social cognition our emotional impairment to explain auditory hallucinations without psychotic symptoms. Methods: Sample of out non-psychotic patients aged six to eighteen years old with auditory hallucinations were recruited with a self report scale created for this study. Mini International Neuropsychiatric Interview (MINI)-kids interview and "psychosis" section od Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia for school age chidlren) were conducted to determine Diagnostic and Statistical Manual of Mental Disorders (DSM) IV diagnoses. All children patient were spend specifics social cognition (NeuroPsychologic assessment NEPSY II) and emotional (ifferential Emotions Scale (DES) IV, Beliefs About Voices Questionnaire Revised (BAVQ-R)) scales. Each child results will be compared to child result of the same age, sex and diagnosis but without hallucination that passed the same specifics scales. All of child will be control after a six month period to evaluate auditory hallucination persistence and diagnosis evolution. The total period of the study will be twelve month.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 7, 2017
Est. primary completion date July 7, 2017
Accepts healthy volunteers No
Gender All
Age group 6 Years to 18 Years
Eligibility Inclusion Criteria:

- Twenty participants included with auditory hallucination:

- Boy or girl

- French

- Over six years old and under eighteen years old

- DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (Intelligence Quotient (IQ)>70),

- Parental and child consent, affiliated to social security.

- Twenty participants included without auditory hallucination:

- Boy or girl

- French,

- Over six years old and under eighteen years old

- DSM-IV diagnosis of mood disorder, anxiety, disruptive behavioral disorder, attention deficit hyperactivity disorder, without schizophrenia diagnosis, without mental retardation (IQ>70)

- Parental and child consent, affiliated to social security.

Exclusion Criteria:

- schizophrenia diagnosis,

- neurologic, genetic or neurosensory disorders

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Patients with auditory hallucination
Patients with auditory hallucination (20 for each arm): Evaluation at time 0 and 6 month after of: The social cognitive marker (NEPSY II) : theory of mind and affect recognition The emotional marker: Differential emotion scale IV (DES IV): emotional individual stability Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination. Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. Evaluation of diagnosis with DSM-IV criteria: MINI-Kids "Psychosis" section of Kiddie-SADS
Patients without auditory hallucination
Patients without auditory hallucination (20 for each arm): Evaluation at time 0 and 6 month after of: The social cognitive marker (NEPSY II) : theory of mind and affect recognition The emotional marker: Differential emotion scale IV (DES IV): emotional individual stability Revised Beliefs About Voices Questionnaire (BAVQ-R): a self report measure of patients' beliefs, emotional and behavior about auditory hallucination. Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. Evaluation of diagnosis with DSM-IV criteria: MINI-Kids "Psychosis" section of Kiddie-SADS

Locations

Country Name City State
France Fondation Lenval Nice

Sponsors (1)

Lead Sponsor Collaborator
Fondation Lenval

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Evolution of the score of theory of mind The social cognitive marker will be evaluate by NeuroPsychologic assessment NEPSY II for theory of mind Change from baseline 6 month later
Secondary Evolution of the score of auditory hallucinations persistence Evaluation of auditory hallucinations persistence with a self report scale using in recruiting criteria. Change from baseline 6 month later
Secondary Evolution of the score of Mental Disorder Evaluation of diagnosis of Mental Disorder with Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria using MINI-Kids (Mini International Neuropsychiatric Interview ) Change from baseline 6 month later
Secondary Evaluation of the score of Psychosis Evaluation of diagnosis of psychosis with DSM-IV (Diagnostic and Statistical Manual of Mental Disorders ) criteria using "Psychosis" section of Kiddie-SADS (Schedule for Affective Disorders and Schizophrenia for school age chidlren) Change from baseline 6 month later
Secondary Evolution of the score of individual stability The evaluation of the the emotional marker will be performed with the Differential emotion scale IV (DES IV): emotional individual stability Change from baseline 6 month later
Secondary Evolution of measure of recognition of the feelings The measure of recognition of the feelings will be performed by the score:
The social cognitive marker (NEPSY II)
Change from baseline 6 month later
Secondary Evolution of auditory measure of patients' emotional The auditory measure will be performed by the score:
The social cognitive marker (NEPSY II)
Change from baseline 6 month later
Secondary Evolution of Emotional real-life experience of the hallucination The Emotional real-life experience of the hallucination will be performed by the score:
The Revised Beliefs About Voices Questionnaire (BAVQ-R)
Change from baseline 6 month later
Secondary Evolution of the score of affect recognition The social cognitive marker will be evaluate by NeuroPsychologic assessment NEPSY II for theory of affect recognition Change from baseline 6 month later
See also
  Status Clinical Trial Phase
Recruiting NCT06155695 - Auditory Control Enhancement (ACE) in Schizophrenia N/A
Completed NCT00763841 - Transcranial Magnetic Stimulation (TMS) for Treatment of Auditory Hallucinations Phase 1
Active, not recruiting NCT04661163 - CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy N/A
Completed NCT01478880 - Efficacy and Safety of Bilateral Theta Burst Stimulation for the Treatment of Auditory Hallucinations Phase 2
Completed NCT01015001 - A Pilot Double-blind Sham-controlled Trial of Repetitive Transcranial Magnetic Stimulation for Patients With Refractory Schizophrenia Treated With Clozapine Phase 3
Withdrawn NCT02240446 - Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients N/A
Completed NCT02670291 - Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation N/A
Completed NCT01963676 - Transcranial Current Stimulation as a Treatment for Auditory Hallucinations in Schizophrenia N/A
Completed NCT00870909 - Transcranial Direct Current Stimulation (tDCS) and Hallucinations in Schizophrenia N/A